These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24581840)

  • 21. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):404-9. PubMed ID: 18418347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update: influenza activity--United States and worldwide, 1995-96 season, and composition of the 1996-97 influenza vaccine. From the Centers for Disease Control and Prevention.
    JAMA; 1996 May; 275(19):1467-8. PubMed ID: 8622205
    [No Abstract]   [Full Text] [Related]  

  • 23. From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 1994-95 season, and composition of the 1995-96 influenza vaccine.
    JAMA; 1995 May 24-31; 273(20):1565-6. PubMed ID: 7745759
    [No Abstract]   [Full Text] [Related]  

  • 24. Universal influenza vaccine: the holy grail?
    Shaw AR
    Expert Rev Vaccines; 2012 Aug; 11(8):923-7. PubMed ID: 23002973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza in summer 1993.
    Commun Dis Rep CDR Wkly; 1993 Sep; 3(39):177. PubMed ID: 7693205
    [No Abstract]   [Full Text] [Related]  

  • 27. Experience with the clinical development of influenza vaccines for potential pandemics.
    Wood JM; Nicholson KG; Stephenson I; Zambon M; Newman RW; Major DL; Podda A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):197-201. PubMed ID: 12458360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WHO announces flu vaccine formula for 1998-1999.
    Public Health Rep; 1998; 113(3):193. PubMed ID: 9633856
    [No Abstract]   [Full Text] [Related]  

  • 29. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

  • 31. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1993-94 season.
    Can Commun Dis Rep; 1993 May; 19(9):65-71. PubMed ID: 7686070
    [No Abstract]   [Full Text] [Related]  

  • 32. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 33. Avian influenza. Preaching against the pandemic.
    Enserink M
    Science; 2005 Oct; 310(5747):429. PubMed ID: 16239456
    [No Abstract]   [Full Text] [Related]  

  • 34. Update: influenza activity--United States and worldwide, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(38):752-5. PubMed ID: 8371709
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza surveillance in Victoria, 2005.
    Turner JL; Fielding JE; Clothier HJ; Kelly HA
    Commun Dis Intell Q Rep; 2006; 30(1):137-43. PubMed ID: 16637243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO recommendations on the composition of the 2015/16 influenza virus vaccines in the northern hemisphere.
    Eurosurveillance editorial team
    Euro Surveill; 2015 Mar; 20(9):. PubMed ID: 25764193
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations pertaining to the use of viral vaccines: influenza.
    S Afr Med J; 2002 Feb; 92(2):132. PubMed ID: 11894647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.